Simona Gamba
Biographic Data
| ID | 4619320 |
|---|---|
| NAME | Simona Gamba |
| GIVEN NAMES | Simona |
| FAMILY NAME | Gamba |
| SIGNATURE | GAMBA S |
| AFFILIATIONS | Università Cattolica del Sacro Cuore |
| ORCID | 0000-0002-5538-2873 |
| VERIFIED | Yes |
| TOTAL WORKS | 7 |
| TOTAL CITATIONS | 2 |
| WORKS AS AUTHOR | 7 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2017 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 1 |
The 2023 European Commission proposal and the 2024 European Parliament proposal for the EU pharmaceutical legislation
A revision of EU pharma legislation has been voted by Commission and Parliament; • The paper presents the proposed incentives for innovation and access; • The length of regulatory protection is modulated according to addressed health needs; • Provisions to ensure access to new medicines in all EU countries are introduced; • Innovative incentives are proposed to address antimicrobial resistance. A revision of the pharmaceutical legislation is ongo…
An experimental manipulation of divisibility in the public good game
Machine learning and the optimization of prediction-based policies
We present a procedure for the optimal implementation of public policies that involve predicting an individual behavior or characteristic. By linking prediction errors of any given classification model to the resulting social welfare, we provide a simple measure to rank different models and select the optimal one. Such measure is defined as the difference between the social welfare of a given policy and that of an error-free policy, and it is rel…
Covid-19
Biomed Europa
After a brief analysis of the causes underlying the failure of both governments and the pharma industry in terms of preparedness for the COVID‐19 pandemic, and after a discussion of further risks of health emergencies in the coming decades, this paper proposes a new public policy approach. The proposal aims at a major European initiative for the provision of research and development (R&D) in the biomedical field, based on public health priorities…
When the two ends meet
The Effect of Intellectual Property Rights on Domestic Innovation in the Pharmaceutical Sector
The Effect of Intellectual Property Rights on Domestic Innovation in the Pharmaceutical Sector
When the two ends meet
Covid-19
Biomed Europa
After a brief analysis of the causes underlying the failure of both governments and the pharma industry in terms of preparedness for the COVID‐19 pandemic, and after a discussion of further risks of health emergencies in the coming decades, this paper proposes a new public policy approach. The proposal aims at a major European initiative for the provision of research and development (R&D) in the biomedical field, based on public health priorities…
Machine learning and the optimization of prediction-based policies
We present a procedure for the optimal implementation of public policies that involve predicting an individual behavior or characteristic. By linking prediction errors of any given classification model to the resulting social welfare, we provide a simple measure to rank different models and select the optimal one. Such measure is defined as the difference between the social welfare of a given policy and that of an error-free policy, and it is rel…
The 2023 European Commission proposal and the 2024 European Parliament proposal for the EU pharmaceutical legislation
A revision of EU pharma legislation has been voted by Commission and Parliament; • The paper presents the proposed incentives for innovation and access; • The length of regulatory protection is modulated according to addressed health needs; • Provisions to ensure access to new medicines in all EU countries are introduced; • Innovative incentives are proposed to address antimicrobial resistance. A revision of the pharmaceutical legislation is ongo…
An experimental manipulation of divisibility in the public good game
Economics (5 works) · Business (3 works) · Pharmaceutical Economics and Policy (3 works) · Political science (3 works) · Sociology (3 works) · Computer Science (2 works) · Demography (2 works) · Economic growth (2 works) · Experimental Behavioral Economics Studies (2 works) · Intellectual Property and Patents (2 works)